Display options
Share it on

Genet Mol Biol. 2017 Jul-Sep;40(3):591-596. doi: 10.1590/1678-4685-GMB-2016-0249. Epub 2017 Aug 31.

Exome sequencing identifies a novel mutation of the GDI1 gene in a Chinese non-syndromic X-linked intellectual disability family.

Genetics and molecular biology

Yongheng Duan, Sheng Lin, Lichun Xie, Kaifeng Zheng, Shiguo Chen, Hui Song, Xuchun Zeng, Xueying Gu, Heyun Wang, Linghua Zhang, Hao Shao, Wenxu Hong, Lijie Zhang, Shan Duan

Affiliations

  1. Laboratory of Medical Genetics, Center for Birth Defect Research and Prevention, Shenzhen Research Institute of Population and Family Planning, Shenzhen City, People's Republic of China.
  2. College of Pharmacy, Nankai University, Tianjin City, People's Republic of China.

PMID: 28863211 PMCID: PMC5596370 DOI: 10.1590/1678-4685-GMB-2016-0249

Abstract

X-linked intellectual disability (XLID) has been associated with various genes. Diagnosis of XLID, especially for non-syndromic ones (NS-XLID), is often hampered by the heterogeneity of this disease. Here we report the case of a Chinese family in which three males suffer from intellectual disability (ID). The three patients shared the same phenotype: no typical clinical manifestation other than IQ score ≤ 70. For a genetic diagnosis for this family we carried out whole exome sequencing on the proband, and validated 16 variants of interest in the genomic DNA of all the family members. A missense mutation (c.710G > T), which mapped to exon 6 of the Rab GDP-Dissociation Inhibitor 1 (GDI1) gene, was found segregating with the ID phenotype, and this mutation changes the 237th position in the guanosine diphosphate dissociation inhibitor (GDI) protein from glycine to valine (p. Gly237Val). Through molecular dynamics simulations we found that this substitution results in a conformational change of GDI, possibly affecting the Rab-binding capacity of this protein. In conclusion, our study identified a novel GDI1 mutation that is possibly NS-XLID causative, and showed that whole exome sequencing provides advantages for detecting novel ID-associated variants and can greatly facilitate the genetic diagnosis of the disease.

References

  1. Res Dev Disabil. 2010 Nov-Dec;31(6):1216-22 - PubMed
  2. Am J Hum Genet. 2016 Jan 7;98(1):149-64 - PubMed
  3. Mol Neurobiol. 2017 May;54(4):2458-2468 - PubMed
  4. Trends Cell Biol. 2001 Dec;11(12 ):487-91 - PubMed
  5. BMJ. 2008 Dec 08;337:a2507 - PubMed
  6. Traffic. 2001 Aug;2(8):532-43 - PubMed
  7. Lancet. 2012 Nov 10;380(9854):1674-82 - PubMed
  8. BMC Bioinformatics. 2010 Nov 08;11:548 - PubMed
  9. Am J Med Genet A. 2003 Nov 15;123A(1):29-32 - PubMed
  10. Trends Cell Biol. 1996 Aug;6(8):315-20 - PubMed
  11. Nature. 2014 Nov 13;515(7526):209-15 - PubMed
  12. Curr Opin Cell Biol. 2013 Aug;25(4):414-9 - PubMed
  13. J Med Genet. 2006 Mar;43(3):193-200 - PubMed
  14. N Engl J Med. 2012 Nov 15;367(20):1921-9 - PubMed
  15. PLoS One. 2015 Apr 29;10(4):e0124120 - PubMed
  16. J Comput Chem. 2005 Dec;26(16):1668-88 - PubMed
  17. Nat Genet. 1998 Jun;19(2):134-9 - PubMed
  18. Nature. 1996 May 2;381(6577):42-8 - PubMed
  19. J Mol Biol. 2001 Nov 2;313(4):889-901 - PubMed
  20. Nat Cell Biol. 2002 Apr;4(4):E77-8 - PubMed
  21. Genetics. 2004 Feb;166(2):835-81 - PubMed
  22. Bioinformatics. 2007 Nov 1;23(21):2947-8 - PubMed
  23. Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:302-14 - PubMed
  24. Clin Genet. 2011 Aug;80(2):117-26 - PubMed
  25. Am J Med Genet A. 2011 Dec;155A(12):3067-70 - PubMed

Publication Types